A crucial first step: WHO Pandemic Agreement

The WHO Pandemic Agreement directly addresses the risk of zoonotic spillovers — transmission of pathogens from animals to humans. With over a million undiscovered viruses in animal hosts, Raina Plowright and her colleagues urge swift action. 

Around Cornell

Hitting the target: Imaging reveals psilocybin’s neural odyssey

Cornell researchers have identified a pair of key neurological mechanisms in the brain – a cell type and receptor – that enable the psychedelic compound’s long-lasting effects.

Omega-6 fatty acid promotes growth of aggressive type of breast cancer

Linoleic acid enhances the growth of the hard-to-treat “triple negative” breast cancer subtype.

Pregnancy may reduce long COVID risk

Pregnancy may offer some protection from developing long COVID, found a new study led by Weill Cornell Medicine, University of Rochester Medical Center, University of Utah Health and Louisiana Public Health Institute.

AI meets oncology: New model personalizes bladder cancer treatment

Researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.

Weill Family Foundation’s $50M gift establishes Weill Cancer Hub East

Four leading research institutions, including Weill Cornell Medicine, have united under the Weill Cancer Hub East, an innovative, collaborative partnership that aims to transform cancer treatment.

Rooted in a Cornell collaboration, New York state is tops for beets

New York produces 22.2% of the nation's beets, while health-conscious consumers are demanding more products that utilize the earthy root.

Framework offers systems-level analysis of cancer mutations

A study from Cornell researchers could enable a quantum leap forward in identifying and deciphering cancer-driving genetic mutations, the first step in developing effective therapeutics.

Biomarker for most common cancer in young men confirmed

Cornell researchers have confirmed that a previously identified biomarker for detecting malignant testicular germ cell tumors – the most common solid cancers in young men – has the potential to improve patient outcomes through early detection.